Threeshiba: Key Toshiba investor opposes firm's split

3D Investments said plan will result in 'three underperforming companies'


A fund that holds around 7 per cent of Toshiba stock – making it the company's second-largest shareholder – has opposed the Japanese industrial giant's proposed split into three companies, and called for a review of alternative strategies.

A scathing open letter from 3D Investments begins by declaring that the company's "failures of execution and misallocation of capital" are compounded by the board's lack of transparency and have collectively damaged the company's credibility.

The investment firm said Toshiba's strategic review committee (SRC) failed in its attempt to find a plan, with an 8 per cent stock price plunge evidence that the plan to split the company is not a good idea.

"By its own admission, the SRC did not provide detailed information to, or conduct management meetings with, private equity firms, nor did it ever ask for or receive proposals for a sale of the Company or a partial disposition of businesses. It appears from the SRC report that no strategic partners or acquirers were contacted either," 3D Investments fumes.

The firm's main beef seems to be that the SRC and board were too quick to dismiss a strategic partnership with a global private equity firm – and did so to avoid the inconvenience of oversight by such entities.

"So rather than examining the full range of possibilities and reporting on those possibilities to shareholders, the SRC has instead decided that the status quo, with some minor shuffling of businesses into different corporate entities, is the prescription for success, despite years of evidence to the contrary," argues the letter.

3D Investments said the plan as it stands will result in "three underperforming companies in the image of today's Toshiba." But not all hope is lost – the equity biz believes with some more robust changes Toshiba could yet improve its performance and reputation.

The firm urged the SRC and board to go back to square one:

We therefore encourage you to open a formal process, develop a compelling plan for each of the businesses, provide detailed diligence materials and management meetings to interested financial and strategic parties, encourage and enable stretch proposals from those parties and evaluate the best path forward for Toshiba in light of the competitive proposals that we are certain will be submitted.

The plan that the fund so furiously opposes would see Toshiba persist as a vendor of printers, barcode kit, and point-of-sale tech, and sell 40 per cent of the stake it holds in memory maker Kioxia – a 2019 Toshiba spin-off. Profits from Kioxa would be disbursed to shareholders.

Another subsequent company would focus on devices, and inherit Toshiba's semiconductor and hard drive businesses. A third company would provide power generation, IT solutions, batteries, and other infrastructure-related products and services.

Toshiba's interim CEO, Satoshi Tsunakawa, justified the decision at the time of the announcement earlier this month by saying it would "[remove] complexity" and allow for more focused management.

While obviously not everyone is happy about the split – and some are more vocal about this than others – Toshiba made the decision after a reckoning with investors over its culture and scandals. The last straw for some was allegations over management's claimed collusion with Japan's trade ministry to bully shareholders into voting for their preference. The firm has denied these allegations.

A five-month review followed that included talks with private equity firms. Toshiba said any potential offers were "not compelling relative to market expectations." ®

Similar topics


Other stories you might like

  • Google sours on legacy G Suite freeloaders, demands fee or flee

    Free incarnation of online app package, which became Workplace, is going away

    Google has served eviction notices to its legacy G Suite squatters: the free service will no longer be available in four months and existing users can either pay for a Google Workspace subscription or export their data and take their not particularly valuable businesses elsewhere.

    "If you have the G Suite legacy free edition, you need to upgrade to a paid Google Workspace subscription to keep your services," the company said in a recently revised support document. "The G Suite legacy free edition will no longer be available starting May 1, 2022."

    Continue reading
  • SpaceX Starlink sat streaks now present in nearly a fifth of all astronomical images snapped by Caltech telescope

    Annoying, maybe – but totally ruining this science, maybe not

    SpaceX’s Starlink satellites appear in about a fifth of all images snapped by the Zwicky Transient Facility (ZTF), a camera attached to the Samuel Oschin Telescope in California, which is used by astronomers to study supernovae, gamma ray bursts, asteroids, and suchlike.

    A study led by Przemek Mróz, a former postdoctoral scholar at the California Institute of Technology (Caltech) and now a researcher at the University of Warsaw in Poland, analysed the current and future effects of Starlink satellites on the ZTF. The telescope and camera are housed at the Palomar Observatory, which is operated by Caltech.

    The team of astronomers found 5,301 streaks leftover from the moving satellites in images taken by the instrument between November 2019 and September 2021, according to their paper on the subject, published in the Astrophysical Journal Letters this week.

    Continue reading
  • AI tool finds hundreds of genes related to human motor neuron disease

    Breakthrough could lead to development of drugs to target illness

    A machine-learning algorithm has helped scientists find 690 human genes associated with a higher risk of developing motor neuron disease, according to research published in Cell this week.

    Neuronal cells in the central nervous system and brain break down and die in people with motor neuron disease, like amyotrophic lateral sclerosis (ALS) more commonly known as Lou Gehrig's disease, named after the baseball player who developed it. They lose control over their bodies, and as the disease progresses patients become completely paralyzed. There is currently no verified cure for ALS.

    Motor neuron disease typically affects people in old age and its causes are unknown. Johnathan Cooper-Knock, a clinical lecturer at the University of Sheffield in England and leader of Project MinE, an ambitious effort to perform whole genome sequencing of ALS, believes that understanding how genes affect cellular function could help scientists develop new drugs to treat the disease.

    Continue reading

Biting the hand that feeds IT © 1998–2022